Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BGB-43395 |
Trade Name | |
Synonyms | BGB43395|BGB 43395 |
Drug Descriptions |
BGB-43395 selectively inhibits CDK4, potentially resulting in cell cycle arrest and decreased tumor cell proliferation (NCI Drug Dictionary). |
DrugClasses | CDK4 Inhibitor 17 |
CAS Registry Number | NA |
NCIT ID | C203660 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BGB-21447 + BGB-43395 + Fulvestrant | BGB-21447 BGB-43395 Fulvestrant | 0 | 1 |
BGB-43395 | BGB-43395 | 0 | 1 |
BGB-43395 + Fulvestrant | BGB-43395 Fulvestrant | 0 | 1 |
BGB-43395 + Letrozole | BGB-43395 Letrozole | 0 | 1 |